Arthur Andersen

Report of Independent Public Accountants

To the Trustees of
Manville Personal Injury Settlement Trust:

We have audited the accompanying special-purpose consolidated statements of net claimants’ equity of Manville Personal Injury Settlement Trust (the "Trust"), organized in the state of New York) as of December 31, 1999 and1998, and the related statements of changes in net claimants' equity and cash flows for the years then ended. These special-purpose consolidated financial statements and the exhibits referred to below are the responsibility of the Trust's management. Our responsibility is to express an opinion on these special-purpose consolidated financial statements and exhibits based on our audits.

We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

As described in Note 2, these special-purpose consolidated financial statements were prepared on a special-purpose basis of accounting and are not intended to be a presentation in conformity with generally accepted accounting principles. The special-purpose basis of accounting has been used in order to better communicate the amount of equity presently available to current and future claimants.

In our opinion, the accompanying special-purpose consolidated financial statements of Manville Personal Injury Settlement Trust as of and for the years ended December 31, 1999 and 1998, are fairly presented, in all material respects, on the basis of accounting described in Note 2.

Our audits were made for the purpose of forming an opinion on the special-purpose consolidated financial statements taken as a whole. The supplementary schedules at Exhibits I, II, and III are presented for purposes of additional analysis and are not a required part of the special-purpose consolidated financial statements. This information has been subjected to the auditing procedures applied in our audits of the special-purpose consolidated financial statements and, in our opinion, is fairly stated in all material respects in relation to the special-purpose consolidated financial statements taken as a whole.

This report is intended solely for the information and use of the management of the Trust, the Trustees, the beneficiaries of the Trust, Johns Manville Corporation, and the United States Bankruptcy Court for the Southern District of New York and is not intended to be and should not be used by anyone other than these specified parties. This restriction is not intended to limit the distribution of this report which, upon filing with the United States Bankruptcy Court for the Southern District of New York, is a matter of public record.

/s/ ARTHUR ANDERSEN, LLP

Vienna, Virginia
February 2, 2000


 MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED STATEMENTS OF NET CLAIMANTS' EQUITY
AS OF DECEMBER 31, 1999 AND 1998

                            1999

1998

ASSETS:
                Cash equivalents and investments (Notes 1 & 2)
                         Available-for-sale non-JM
                                     Restricted (Note 8)

$49,630,623

$49,426,235

                                     Unrestricted non-JM

945,200,542

970,250,888

                                                   Total

994,831,165

1,019,677,123

                         Other available-for-sale
                                     JM common stock

1,571,185,790

2,053,489,371

                         Held-to-maturity securities
                                     Trust Second Bond

26,852,366

                                                  Total cash equivalents and investments

2,566,016,955

3,100,018,860

                Accrued interest and dividend receivables

15,426,902

16,928,255

                Deposits and other assets

181,637

284,699

                         Total assets

2,581,625,494

3,117,231,814

LIABILITIES:
                Accrued expenses

4,975,469

3,785,711

                Unpaid claims (Notes 4, 6 & Exh. III)
                         Settled Pre-Class Action complaint

1,522,673

2,429,040

                         Outstanding Offers - Post Class Action complaint

93,283,702

52,907,100

                Contribution and indemnity claims payable
                         (Notes 4, 8 and Exh. III)

6,630,836

8,397,490

                Lease commitments payable (Note 5)

2,551,719

3,143,884

                         Total liabilities

108,964,399

70,663,225

NET CLAIMANTS' EQUITY (Note 6)

$2,472,661,095

$3,046,568,589

The accompanying notes are an integral part of these statements.


MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED STATEMENTS OF CHANGES IN NET CLAIMANTS' EQUITY
FOR THE YEARS ENDED DECEMER 31, 1999 AND 1998

1999

1998

NET CLAIMANTS' EQUITY,
          BEGINNING OF PERIOD

$3,046,568,589

$2,251,315,377

ADDITIONS TO NET CLAIMANTS' EQUITY:
          JM dividend

28,518,949

25,129,422

          Reimbursement by JM of prior years foreign income taxes

355,523

          Trust Second  Bond accretion (Note 2c)

6,363,350

2,859,755

          Non-JM investment income (Exh. I)

46,287,440

59,153,999

          Gain on sale of JM stock

63,115,810

46,800,000

         Unrealized gain on JM stock

760,185,327

         Net unrealized gains on non-JM available-for-sale   
              securities

26,039,718

38,971,098

          Decrease in lease commitments payable

592,165

448,169

                 Total additions

171,272,955

933,547,770

DEDUCTIONS FROM NET CLAIMANTS' EQUITY:
          Operating and dispute resolution expenses (Exh. II)

17,423,345

11,513,163

          Management expenses for investments in JM 

2,243,540

767,528

          Net increase in outstanding claim offers 

40,376,602

15,973,992

         Claims settled

302,767,388

107,720,861

          Contribution and indemnity claims settled

3,734,466

2,319,014

          Unrealized loss on JM stock  

378,635,108

                    Total deductions

745,180,449

138,294,558

NET CLAIMANTS' EQUITY,
          END OF PERIOD

$2,472,661,095

$3,046,568,589

The accompanying notes are an integral part of these statements.    


MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED STATEMENTS OF CASH FLOWS 
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998

 
1999

 
1998

CASH INFLOWS:
          JM dividends

$29,250,730

$22,774,879

          Reimbursement by JM of prior years foreign income taxes

355,523

          Proceeds from sale of JM stock

166,784,284

46,800,000

         Proceeds from Trust Second Bond prepayment

33,215,716

          Investment receipts

47,586,803

58,388,231

          Investment receipts on escrow accounts (Note 8)

204,388

182,348

                    Total cash inflows

277,397,444

128,145,458

CASH OUTFLOWS:
          Claim payments made

303,706,575

108,069,697

          Contribution and indemnity claim payments

5,708,508

12,600,467

                    Total cash claim payments

309,412,083

120,670,164

          Disbursements for Trust operating, dispute resolution,
             and asset management

18,974,099

11,319,565

                    Total cash outflows

328,386,182

131,989,729

NET CASH OUTFLOWS

(50,988,738)

(3,844,271)

          Net unrealized gains on non-JM
                    available-for-sale securities

26,039,718

38,971,098

          Change in deposits and other assets

103,062

(167,359)

NET (DECREASE) INCREASE IN CASH EQUIVALENTS AND
          NON-JM INVESTMENTS AVAILABLE-FOR-SALE

(24,845,958)

34,959,468

CASH EQUIVALENTS AND NON-JM INVESTMENTS
          AVAILABLE-FOR-SALE, BEGINNING OF PERIOD

1,019,677,123

984,717,655

CASH EQUIVALENTS AND NON-JM INVESTMENTS
          AVAILABLE-FOR-SALE, END OF PERIOD

$994,831,165

$1,019,677,123

The accompanying notes are an integral part of these statements.


MANVILLE PERSONAL INJURY SETTLEMENT TRUST

Special-Purpose Consolidated Financial Statements
For the Years Ended December 31, 1999 and 1998
Together With Auditors’ Report


MANVILLE PERSONAL INJURY SETTLEMENT TRUST
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 1999 AND 1998

 

(1)    DESCRIPTION OF THE TRUST

The Manville Personal Injury Settlement Trust (the Trust), organized pursuant to the laws of the state of New York with its office in Katonah, New York, was established pursuant to the Manville Corporation (Manville) Second Amended and Restated Plan of Reorganization (the Plan). The Trust was formed to assume Manville’s liabilities resulting from pending and potential litigation involving (i) individuals exposed to asbestos who have manifested asbestos-related diseases or conditions, (ii) individuals exposed to asbestos who have not yet manifested asbestos-related diseases or conditions and (iii) third-party asbestos-related claims against Manville for indemnification or contribution. Upon consummation of the Plan, the Trust assumed liability for existing and future asbestos health claims. The Trust had initial funding and will receive ongoing fixed and contingent funding as described below under "Funding of the Trust." The Trust’s funding is dedicated solely to the settlement of asbestos health claims and the related costs thereto, as defined in the Plan. The Trust was consummated on November 28, 1988.

In December 1998, the Trust formed a wholly-owned corporation, the Claims Resolution Management Corporation (CRMC), to provide the Trust with claim processing and settlement services. Prior to January 1, 1999, the Trust provided its own claim processing and settlement services. CRMC began operations on January 1, 1999 in Fairfax, Virginia. The accounts of the Trust and CRMC have been consolidated for financial reporting purposes. All significant balances and transactions between the Trust and CRMC have been eliminated in consolidation.

Funding of the Trust

The Trust was initially funded from the following sources:

Manville Stock Interests

In March 1996, Manville changed its name to Schuller Corporation (Schuller). In May 1997, Schuller changed its name to Johns Manville Corporation (JM). On April 13, 1998 JM purchased 3.6 million shares of its common stock from the Trust at $13 per share, the average of the closing prices between March 12 and April 8, 1998. The Trust received $46.8 million from the sale of the JM common stock.

On July 7, 1999 JM purchased approximately 12.2 million shares of its common stock from the Trust for approximately $166.8 million. Based on an agreement reached between the Trust and JM on June 7, 1999, the shares were purchased at the average closing price of $13.675, JM’s common stock for the 20 business days beginning June 8, 1999 and ending July 6, 1999. After giving effect to the transaction, the Trust owns 112,730,819 shares of JM common stock or approximately 76% of outstanding shares. The Trust continues to explore strategic alternatives for further diversifying the Trust estate.

(2) SIGNIFICANT ACCOUNTING POLICIES

(a) Basis of Presentation

The Trust’s financial statements are prepared using special-purpose accounting methods that differ from generally accepted accounting principles (GAAP). The special-purpose accounting methods were adopted in order to better communicate to the beneficiaries of the Trust the amount of equity available for payment of current and future claims. These special-purpose accounting methods are enumerated as follows:

  1. The financial statements are prepared using the accrual basis of accounting.
  2. The funding received from JM and its liability insurers has been recorded directly to net claimants’ equity. These funds do not represent income of the Trust. Settlement offers for asbestos health claims are reported as deductions in net claimants’ equity and do not represent expenses of the Trust.
  3. Costs of non-income producing assets, which will be exhausted during the life of the Trust and are not available for satisfying claims, are expensed as they are incurred. These costs include acquisition costs of computer hardware, software, software development, office furniture and leasehold improvements.
  4. Future fixed liabilities and contractual obligations entered into by the Trust are recorded directly against net claimants’ equity. Accordingly, the future minimum rental commitments outstanding at period end for non-cancelable operating leases, net of any sublease agreements, have been recorded as deductions to net claimants’ equity.
  5. The liability for unpaid claims reflected in the statements of net claimants’ equity represents settled but unpaid claims and outstanding settlement offers. Post-Class Action complaint claims’ liability is recorded once a settlement offer is made to the claimant (Note 4) at the amount equal to the expected pro rata payment. No liability is recorded for future claim filings and filed claims on which no settlement offer has been made. Net claimants’ equity represents funding available to pay present and future claims on which no fixed liability has been recorded.
  6. Available-for-sale securities are recorded at market. Held-to-maturity securities are recorded at amortized cost. All interest and dividend income, as well as net realized gains/losses, on non-JM available-for-sale securities are included in non-JM investment income on the statements of changes in net claimants’ equity. Realized gains on JM common stock and unrealized gains and losses on non-JM available-for-sale securities are recorded as separate components on the statements of changes in net claimants’equity.

The preparation of financial statements in conformity with the special-purpose accounting methods described above requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of additions and deductions to net claimants’ equity during the reporting period. Actual results could differ from those estimates. The most significant estimates with regard to these financial statements relate to unpaid claims, as discussed in Notes 4 and 6.

(b) JM Common Stock Interest

The Trust’s stock interests represent a majority stock interest in JM. The accounts of JM have not been consolidated in the accompanying financial statements because: (i) JM stock interests are held by the Trust in order to pay asbestos health claims, and as such, the investment is likely to be temporary; and (ii) the objective of the financial statements is to communicate the equity available over the life of the Trust to current and future claimants. Thus, the Trust believes that recording these stock interests at current market value is appropriate.

At consummation, the Trust’s stock interests were recorded at market value. Subsequent changes in their market values are shown separately as unrealized appreciation/depreciation in the carrying value of JM common stock in the statements of changes in net claimants’ equity. The market value of the JM common stock held by the Trust is recorded by using the closing price of JM common stock on the New York Stock Exchange composite transactions on the last day of the appropriate reporting period. As of December 31, 1999 and 1998, that price was $13.9375 and $16.4375 per share, respectively. Nevertheless, the Trust may not realize this value as a result of potential illiquidity in the public sale of a major position in JM common stock without disruption to the public market. Further, any premium that might be obtained upon a private sale of a controlling interest in JM may also impact this value.

(c) Trust Second Bond

On June 30, 1999 JM prepaid the Trust Second Bond resulting in the payment to the Trust of $33,215,716, using an agreed-upon discount rate of 10.6% as part of the June 7, 1999 agreement between the Trust and JM (Note 1). The Trust Second Bond was previously reported using a discount rate of 11.75% as agreed upon in the Bond Repurchase Agreement dated September 22, 1994 between the Trust and JM. The discount rate for prior periods had not been adjusted to reflect current interest rates or other market conditions since its market value was not readily ascertainable.

(d) Cash Equivalents and Non-JM Investments

At December 31, 1999 and 1998 the Trust has recorded all its non-JM investment securities at market value, as follows:

                                                                       1999                                             1998                   
     Cost     Market      Cost     Market
Restricted
   Cash equivalents $8,163,247 $8,163,247 $4,230,723 $4,230,723
   U.S. Govt. oblig. 10,297,941 10,118,666 13,331,154 13,402,996
   Corporate and other debts 6,616,342 6,554,126 3,526,663 3,551,938
   Equities - U.S. 14,201,382 24,794,584 24,600,836 28,240,578
   
Total $39,278,912 $49,630,623 $45,689,376 $49,426,235

 

Unrestricted
   Cash equivalents

$187,773,048

$187,773,048

$98,051,017

$98,051,017

   U.S. govt. obligations 193,971,035 187,739,337

499,158,265

503,279,803

   Foreign govt. obligations 104,116,650 105,041,002 99,366,158 102,204,285
   Corporate and other debt 220,890,947 214,265,671 72,589,830 73,162,639
   Equities - U.S. 100,365,479 161,724,357 86,407,257 126,034,423
   Equities - International 60,697,725 88,657,127 56,717,568 67,518,721
                Total $867,814,884 $945,200,542 $912,290,095 $970,250,888


The maturities of the Trust's non-JM available-for-sale securities at market value (excluding cash
equivalents) are as follows:

Less Than
1 Year
After 1 Year
Through 5 Years
After 5 Years
Through 10 years
After 10 Yrs
U.S. govt. obligations $8,167,953 $57,116,259 $19,746,612 $112,827,179
Foreign govt. obligations 22,492,478 25,863,957 48,148,707 8,535,860
Corporate and other debt 19,133,017 133,534,040 38,114,272 30,038,468
                Total $49,793,448 $216,514,256 $106,009,591 $151,401,507

The Trust invests in two types of derivative financial instruments. Equity index futures are used as strategic substitutions to cost effectively replicate the underlying index of its domestic equity investment fund. At December 31, 1999, the fair value of these instruments was approximately $4.4 million and was included in non-JM investments available-for-sale on the statement of net claimants’ equity. Foreign currency forwards are utilized for both currency translation purposes and to hedge against the currency risk inherent in foreign bond issues. At December 31, 1999, the Trust held at market value approximately $123.8 million in sell currency forward contracts offset by approximately $122.8 million in buy currency forward contracts. The unrealized gains on these outstanding currency forward contracts of approximately $1.0 million is principally offset by corresponding unrealized losses due to currency exchange on the underlying securities being hedged. These amounts are recorded in the statement of changes in net claimants’ equity at December 31, 1999.

(e) Fixed Assets

The cost of non-income producing assets that will be exhausted during the life of the Trust and are not available for satisfying claims are expensed as incurred. Since inception, these costs, net of disposals, include:

           Acquisition of furniture and equipment  

$ 750,756

           Acquisition of computer hardware and software

1,424,903

           Leasehold improvements

           42,011

           Total

    $2,217,670

These items have not been recorded as assets, but rather as direct deductions to net claimants’ equity in the accompanying financial statements. The cost of fixed assets, net of proceeds on disposals, that were expensed during the years ended December 31, 1999 and 1998 was approximately $228,900 and $243,800, respectively.

Depreciation expense related to asset acquisitions using generally accepted accounting principles would have been approximately $247,400 and $203,800 for the years ended December 31, 1999 and 1998, respectively.

(f)    JM Dividends

Beginning in August 1996, the JM Board of Directors declared regular quarterly dividends of $.03 per share, the first time such dividends were declared since 1982. In August 1997 the dividend was increased to $.04 per share and in August 1998 to $.06 per share. Such dividends are reported as additions to net claimants’ equity.

(3)    LITIGATION

During March 1999, the Trust and the Maritime Asbestosis Legal Clinic (MALC) reached a settlement agreement in the litigation brought by MALC against the Trust in response to the Trust’s disqualifying approximately 27,000 of MALC’s claims due to inadequate documentation and lacking credibility and reliability. The settlement terms are confidential, but provided that certain MALC claims would be paid and others would have to be refiled.

In December 1997, the Trust filed a civil action in the United States District Court for the Eastern District of New York (the Court) against seven tobacco companies to recover reimbursements for all past sums paid by the Trust to individuals whose asbestos disease or illness was caused in whole or in part, or was increased in severity, by the smoking-related illness which the tobacco defendants caused. The defendants have filed answers denying the allegations in the complaint. On November 2, 1999, the Honorable Jack B. Weinstein dismissed the Trust’s suit for lack of subject matter jurisdiction. The Trust has filed a Notice of Appeal of the dismissal. On November 11, 1999, the Trust filed a new action, which in addition to state law claims previously alleged, asserts RICO violations by the defendants. Specifically, the Trust’s new suit alleges claims for contribution, indemnity, unfair competition and unjust enrichment for which it also seeks restitution and punitive damages and it alleges RICO violations for which it seeks treble damages and disgorgement. Trial has been set for April 17, 2000.

In September 1998, the Trust, Trustees and certain officers and employees of the Trust were sued by certain claimants who alleged breach of fiduciary duty and breach of the terms of the Trust Distribution Process with respect to certain medical audit procedures. The Trustees and said officers and employees were dismissed from those suits that named them as defendants. A settlement between the remaining parties was agreed to on April 9, 1999 and approved by the Court on May 20, 1999. The settlement terminates the previous medical audit procedures and, subject to new medical audit procedures, provides for the payment of certain claims filed through April 9, 1999.

(4)    UNPAID CLAIMS

The Trust distinguishes between claims that were resolved prior to the filing of the class action complaint on November 19, 1990 and claims resolved after the filing of that complaint. Claims resolved prior to the complaint (Pre-Class Action Claims) were resolved under various payment plans, all of which called for 100% payment of the full liquidated amount without interest over some period of time. However, between July 1990 and February 1995, payments on all claims except qualified exigent health and hardship claims were stayed by the Courts. By Order of the Courts on July 22, 1993 (which became final on January 11, 1994), a plan submitted by the Trust was approved to immediately pay, subject to claimant approval, a discounted amount on Pre-Class Action Claims, in full satisfaction of these claims. The discount amount taken, based on the claimants who accepted the Trust’s discounted offer, was approximately $135 million.

The unpaid liability for the Post-Class Action claims represents outstanding offers made in First-in, First-out (FIFO) order to claimants eligible for settlement after November 19, 1990. Under the TDP (Note 6), claimants receive an initial pro rata payment equal to 10% of the liquidated value of their claim. The Trust remains liable for the unpaid portion of the liquidated amount only to the extent that assets will be available after paying all claimants the established pro rata share of their claims. The Trust makes these offers in the form of a check made payable to the claimant and/or claimant’s counsel. If the offer is accepted, the check is deposited, a Trust release is completed and the claim is recorded as settled. An unpaid claim liability is recorded once an offer is made. The unpaid claim liability remains on the Trust’s books until accepted or expiration of the offer after 180 days. A claimant may request that an offer be extended for an additional 180 days.

Pursuant to the Stipulation of Settlement, the Trust is obligated to pay approximately $63 million plus investment earnings on funds set aside for contribution and indemnity claims occurring before July 25, 1994. To date, the Trust has paid approximately $60 million under this obligation.

(5) COMMITMENTS AND CONTINGENCIES

Operating Leases

In September 1993, the Trust executed a 5-year lease through December 1998 for its offices in Fairfax, Virginia. The lease was extended for an additional 5 years beginning at the expiration of the current lease. Effective January 1, 1999, the Trust assigned its rights under the lease to CRMC conditioned upon the Trust’s guarantee of future lease payments.

Future minimum rental commitments under this operating lease, as of December 31, 1999 are as follows:

                                            Calendar Year       Amount

2000               $609,930
2001                 628,228
2002                 647,075
2003                 666,486

   Total         $2,551,719

This obligation has been recorded as a liability at face value in the accompanying financial statements.

(6) NET CLAIMANTS’ EQUITY

A class action complaint was filed on behalf of all Trust beneficiaries on November 19, 1990, seeking to restructure the methods by which the Trust administers and pays claims. On July 25, 1994, the parties signed a Stipulation of Settlement that included a revised Trust Distribution Process (the TDP). The TDP prescribes certain procedures for distributing the Trust’s limited assets, including pro rata payments and initial determination of claim value based on scheduled diseases and values. The Court approved the settlement in an order dated January 19, 1995. Though six appeals were filed with the Court of Appeals, no stay was granted and the Trust implemented the TDP payment procedures effective February 21, 1995. On February 21, 1996, the Court of Appeals affirmed the decision.

Prior to the commencement of the class action in 1990, the Trust filed a motion for a determination that its assets constitute a "limited fund" for purposes of Federal Rules of Civil Procedure 23(b)(1)(B). The Courts adopted the findings of the Special Master that the Trust is a "limited fund". In part, the limited fund finding concludes that there is a substantial probability that estimated future assets of the Trust are and will be insufficient to pay in full all claims that have been and will be asserted against the Trust.

The TDP contains certain procedures for the distribution of the Trust’s limited assets. Under the TDP, the Trust forecasts its anticipated annual sources and uses of cash until the last projected future claim has been paid. A pro rata payment percentage is calculated such that the Trust will have no remaining assets or liabilities after the last future claimant receives his/her pro rata share.

The Trust has conducted its own research and monitored studies prepared by the Courts’ appointee regarding the valuation of Trust assets and liabilities. Based on this valuation, the TDP provides for an initial 10% payment of the liquidated value of current and future claims. Accordingly, the Trust has reported Post-Class Action Claims at 10% of their liquidated value. The 10% pro rata payment represents the Trust’s best estimate of funds available over the life of the Trust to pay claims settled under the TDP. The Trust will continue to monitor this estimate based on changes in settlement practices and changes in future projected values of Trust assets and liabilities and make any necessary changes in the pro rata payment percentage as required under the TDP.

(7) EMPLOYEE BENEFIT PLANS

The Trust established a tax-deferred employee savings plan under Section 401(k) of the Internal Revenue Code, with an effective date of January 1, 1988. The plan allows employees to defer a percentage of their salaries within limits set by the Internal Revenue Code with the Trust matching contributions by employees of up to 6% of their salaries. The total employer contributions and expenses under the plan were approximately $254,600 and $284,200 for the years ended December 31, 1999 and 1998, respectively.

(8) RESTRICTED ASSETS

In order to avoid the high costs of director and officer liability insurance and with the approval of the United States Bankruptcy Court for the Southern District of New York, the Trust established a segregated security fund of $30,000,000 and, with the additional approval of the United States District Court for the Southern and Eastern Districts of New York, an escrow fund of $3,000,000 from the assets of the Trust, which are devoted exclusively to securing the obligations of the Trust to indemnify the former and current Trustees and officers, employees, agents and representatives of the Trust. In addition, a $15,000,000 escrow and security fund was established to secure the obligations of the Trust to exclusively indemnify the current Trustees, whose access to the other security funds is subordinated to the former Trustees. Upon the final order in the Class Action litigation (Note 4), the $15,000,000 escrow and security fund was reduced by $5,000,000. Pursuant to Section 5.07 of the plan, Trustees are entitled to a lien on the segregated security and escrow funds to secure the payment of any amounts payable to them through such indemnification. Accordingly, in total $43 million has been transferred from the Trust’s bank accounts to separate escrow accounts and pledge and security agreements have been executed perfecting those interests. The investment earnings on these escrow accounts accrue to the benefit of the Trust and are recorded as unrestricted investments.

Pursuant to the Stipulation of Settlement, the Trust funded separate investment accounts for two of the sub-class beneficiaries. During 1996, one of these accounts was fully disbursed and the remaining balance for the other account at December 31, 1999 is $6.6 million. This balance and the $43 million of self-insurance funds described above, have been reported as restricted investments.

(9)    INCOME TAXES

For Federal income tax purposes, JM has elected for the qualified assets of the Trust to be taxed as a "Designated Settlement Fund." Income and expenses associated with these qualified assets of the Trust are taxed in accordance with Section 468B of the Internal Revenue Code. JM is obligated to indemnify the Trust for any income tax liability imposed upon the Trust, and accordingly, no liability or income tax provision has been recorded for the Trust. JM is not obligated to pay the federal and state income taxes of CRMC and the provision for income taxes on Exhibit II is the responsibility of CRMC.

The Trust accounts for CRMC’s income taxes in accordance with the Statement of Financial Accounting (SFAS) No. 109, "Accounting for Income Taxes." SFAS No. 109 requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the book and tax basis of assets and liabilities. As of December 31, 1999, the Trust has recorded a net deferred tax asset of $32,000, representing temporary timing differences primarily for CRMC’s accrued vacation and deferred compensation. The deferred asset is included in deposits and other assets in the accompanying consolidated statement of net claimants’ equity.

To the extent that JM has a residual interest in any assets of the Trust or such assets represent stock or indebtedness of JM, the income and expenses attributable to such assets are taxed as if these assets were in a "Grantor Trust." In addition, for tax purposes the Trust has segregated at times certain non-JM available-for-sale securities that are held in a Grantor Trust Account. Consequently, income and expenses associated with these assets are included in the income tax return of JM (the Grantor) and are not part of the Designated Settlement Fund.

(10)    PROOF OF CLAIMS FILED

Proof of claim forms have been filed with the Trust as follows:

                     As of
                   12/31/99

                       As of
                    12/31/98

Claims filed

428,409

396,134

Voided claims (1)

(36,538)

(13,497)

Currently disqualified (2)

(1,390)

(27,488)

Expired offers (3)

(32,018)

(27,240)

            Active claims

358,463

327,909

Settled claims  

(276,682)

(193,949)

Claims currently eligible for settlement

81,781

133,960

(1) Claim filings that are permanently ineligible due to duplication of filing, withdrawal or missing
     critical information.

(2) Claim filings on hold until representation or content problems are resolved.

(3) Claims that received a Trust offer, but failed to respond within the offer acceptance period.
     A claim may be reactivated upon written request and is eligible for a new offer at the end of
     the FIFO queue.


The following exhibits are provided in accordance with Article 3.02 (d) (iii) of the Manville Personal Injury Settlement Trust Agreement.

    Exhibit I   Consolidated Non-JM Investment Income for the Years Ended
    December 31, 1999 and 1998

    Exhibit II  Consolidated Operating and Dispute Resolution Expenses for the
    Years Ended December 31, 1999 and 1998

    Exhibit III, Page 1 - Schedule of Liquidated Claims Since Consummation
    (November 28, 1988) Through December 31, 1999

    Exhibit III, Page 2 - Schedule of Liquidated Claims for the Year Ended
    December 31, 1999


                                                                                                                                   EXHIBIT I

MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED NON-JM INVESTMENT INCOME
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998


1999


1998

NON-JM INVESTMENT INCOME
         Interest

$50,006,268

$47,479,235

         Dividends

3,356,045

3,036,582

         Net realized (losses) gains

(4,920,633)

10,407,992

                     Total non-JM investment income

48,441,680

60,923,809

          Investment expenses

(2,154,240)

(1,769,810)

TOTAL

$46,287,440

$59,153,999

The accompanying notes are an integral part of this exhibit.


                                                                                                                                        EXHIBIT II

MANVILLE PERSONAL INJURY SETTLEMENT TRUST
CONSOLIDATED OPERATING AND DISPUTE RESOLUTION EXPENSES
FOR THE YEARS ENDED DECEMBER 31, 1999 AND 1998


1999
         

    
1998     

OPERATING EXPENSES:
      Personnel costs

$7,204,652

$6,470,098

      Office general and administrative

1,350,797

1,161,626

      Travel and meetings

272,203

218,225

      Board of Trustees

552,430

386,417

      Professional fees

7,437,015

2,891,347

      Net fixed asset purchases

228,887

243,818

      Computer and other EDP costs

99,645

83,689

      CRMC income taxes

241,100

________

         Total operating expenses

17,386,729

11,455,220

DISPUTE RESOLUTION EXPENSES:
      Litigation defense

26,356

41,993

      Arbitration

10,260

15,950

          Total dispute resolution expenses

36,616

57,943

                 TOTAL

$17,423,345

$11,513,163

The accompanying notes are an integral part of this exhibit.


                                                                                                 EXHIBIT III, Page 1 of 2                                                                                                           

MANVILLE PERSONAL INJURY SETTLEMENT TRUST
SCHEDULE OF LIQUIDATED CLAIMS
SINCE CONSUMMATION (NOVEMBER 28, 1988)
THROUGH DECEMBER 31, 1999


Number


Amount

Average
Payment Amount

Trust Liquidated Claims
     Pre-Class Action Complaint
             November 19, 1990 and Before-
     Liquidated Claim Value

27,610

$1,188,279,972

     Present Value Discount (1)

______

(135,306,535)

     Net Settlements

27,610

1,052,973,437

     Payments

(27,548)

(1,051,450,764)

$38,168
     Unpaid Balance

62

$1,522,673

     Post-Class Action Complaint
               After November 19, 1990-
     Offers Made at Full Liquidated Amount

278,762

$12,006,261,570

     Reduction in Claim Value (2)

______

(10,805,357,448)

     Net Offer Amount

278,762

1,200,904,122

     Payments

(249,072)

(1,107,620,420)

$4,447
     Offers Outstanding

29,690

$93,283,702

Manville Liquidated Claims (3)
     Liquidated Claim Value

158

$24,946,620

     Payments

(158)

(24,946,620)

     Unpaid Balance

0

$0

Co-Defendant Liquidated Claims (4)
     Liquidated Claim Value

$87,804,018

     Investment Receipts (5)

2,512,972

     Payments

(83,686,154)

     Unpaid Balance

$6,630,836

(1)    The unpaid liability for Pre-Class Action Complaint claims has been reduced based upon a plan approved by the Courts in
        January, 1994 which requires the Trust to offer to pay a discounted amount in full satisfaction of the unpaid  claim amount.

(2)   Under the TDP, Post Class Action Complaint claims have been reported at 10% of their liquidated value.

(3)    Manville Liquidated Claims refers to Liquidated AH Claims (as defined in the Plan) which the Trust has paid or accrued as
         payable pursuant to an order of the United States Bankruptcy Court  for the Southern District of New York dated January 27, 1987.

(4)    Number of personal injury claimants not identifiable.

(5)    Investment receipts of separate investment escrow account established for the sub-class beneficiaries per the Stipulation of
        Settlement, net of income taxes.

                                              The accompanying notes are an integral part of this exhibit.


                                                                                      EXHIBIT III,  Page 2 of  2
                                                                                                                 

MANVILLE PERSONAL INJURY SETTLEMENT TRUST
SCHEDULE OF LIQUIDATED  CLAIMS
FOR THE YEAR ENDED DECEMBER 31, 1999


Number


Amount

Average
Payment Amount

Trust Liquidated Claims
     Pre-Class Action Complaint
            November 19, 1990 and Before-
            Payable as of December 31, 1998

168

$2,122,518

            Net adjustment (1)

(105)

(353,405)

            Paid (2)

    (1)

(246,440)

            Payable as of December 31, 1999

     62

$1,522,673

     Post-Class Action Complaint
             After November 19, 1990- (3)
             Offers Outstanding as of December 31, 1998

17,066

$52,907,100

             Net Offers Made (4)

95,359

343,836,737

             Offers Accepted/Paid

(82,735)

(303,460,135)

$3,668

             Offers Outstanding as of December 31, 1999

29,690

$93,283,702

Manville Liquidated Claims
             Payable as of December 31, 1998

16

$306,522

             Adjustment (5)

(16)

($306,522)
             Paid ______ ______
             Payable as of December 31, 1999

0

$0

Co-Defendant Liquidated Claims
             Payable as of December 31, 1998

$8,397,490

             Settled

3,734,466